The pharmaceutical sector’s long-term prospects look promising, given the increasing need to treat age-related and chronic diseases. The industry's growth is expected to be significantly propelled by technological advancements in the drug discovery and development process, in addition to the increasing demand.
Given this backdrop, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals, Inc. (SUPN), Eton Pharmaceuticals, Inc. (ETON), and Viatris Inc. (VTRS) to one’s portfolio.
